Go Pro

Pacific Biosciences of California (PACB) Earnings Date, Estimates & Call Transcripts

Pacific Biosciences of California logo
$1.15 0.00 (0.00%)
Closing price 08/14/2026 04:00 PM Eastern
Extended Trading
$1.16 +0.01 (+0.87%)
As of 08/14/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Pacific Biosciences of California Earnings Summary

Pacific Biosciences of California posted Q2 2026 earnings on August 3, 2026, reporting an EPS of -$0.14, which missed the consensus estimate of -$0.13 by $0.01. Quarterly revenue was reported to be $39.01 million, below analyst estimates of $42.90 million. With a trailing EPS of -$0.43, Pacific Biosciences of California's earnings are expected to grow next year, from ($0.52) to ($0.48) per share.

Upcoming Q3
Earnings Date
Nov. 3After Market ClosesEstimated
Consensus EPS
(Aug. 3)
-$0.13
Actual EPS
(Aug. 3)
-$0.14 Missed By -$0.01
Actual Revenue
(Aug. 3)
$39.01M

Q2 2026 Earnings Resources

PACB Upcoming Earnings

Pacific Biosciences of California's next earnings date is estimated for Tuesday, November 3, 2026, based on past reporting schedules.

Get Pacific Biosciences of California Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Pacific Biosciences of California and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

PACB Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

PACB Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Pacific Biosciences of California Analyst EPS Estimates

Current Year EPS Consensus Estimate
($0.52) EPS
Next Year EPS Consensus Estimate
($0.48) EPS

Pacific Biosciences of California Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
11/3/2026
(Estimated)
--------
8/3/2026Q2 2026-$0.1280-$0.14 -$0.0120-$0.14$42.90M$39.01M
5/7/2026Q1 2026-$0.17-$0.12+$0.05-$0.03$39.94M$37.18M
2/12/2026Q4 2025-$0.19-$0.12+$0.07-$0.13$44.60M$44.65M
11/5/2025Q3 2025-$0.16-$0.12+$0.04-$0.13$40.25M$38.44M
8/7/2025Q2 2025-$0.18-$0.13+$0.05-$0.14$36.35M$39.77M
5/8/2025Q1 2025-$0.19-$0.15+$0.04-$1.44$36.90M$37.15M
2/13/2025Q4 2024-$0.20-$0.20--$0.49$39.20M$39.22M

Pacific Biosciences of California Earnings - Frequently Asked Questions

Pacific Biosciences of California has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 3rd, 2026 based off last year's report dates. Learn more on PACB's earnings history.

Pacific Biosciences of California issued an update on its FY 2026 earnings guidance on Wednesday, August, 5th. The company issued revenue guidance of $155.0 million-$165.0 million, compared to the consensus revenue estimate of $167.4 million.

In the previous quarter, Pacific Biosciences of California (NASDAQ:PACB) missed the analysts' consensus estimate of ($0.13) by $0.01 with a reported earnings per share (EPS) of ($0.14). Learn more on analysts' earnings estimate vs. PACB's actual earnings.

The conference call for Pacific Biosciences of California's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Pacific Biosciences of California's latest earnings report can be read online.
Read Transcript

Pacific Biosciences of California's earnings report can be found in their filing with the SEC.
View SEC filing

Pacific Biosciences of California (NASDAQ:PACB) has a recorded annual revenue of $160.01 million.

Pacific Biosciences of California (NASDAQ:PACB) has a recorded net income of -$546.38 million. PACB has generated -$0.43 earnings per share over the last four quarters.

Pacific Biosciences of California's earnings are expected to grow from ($0.52) per share to ($0.48) per share in the next year.


Earnings data for NASDAQ:PACB is sourced from Fiscal.ai, with the most recent quarter reported on 8/3/2026. New results are added as companies report their earnings.
From Our Partners